• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎防护策略中的关键弱点。

Critical weaknesses in shielding strategies for COVID-19.

作者信息

Smith Cameron A, Yates Christian A, Ashby Ben

机构信息

Department of Mathematical Sciences, University of Bath, Bath, United Kingdom.

Milner Centre for Evolution, University of Bath, Bath, United Kingdom.

出版信息

PLOS Glob Public Health. 2022 Apr 26;2(4):e0000298. doi: 10.1371/journal.pgph.0000298. eCollection 2022.

DOI:10.1371/journal.pgph.0000298
PMID:36962415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10021285/
Abstract

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has led to a wide range of non-pharmaceutical interventions being implemented around the world to curb transmission. However, the economic and social costs of some of these measures, especially lockdowns, has been high. An alternative and widely discussed public health strategy for the COVID-19 pandemic would have been to 'shield' those most vulnerable to COVID-19 (minimising their contacts with others), while allowing infection to spread among lower risk individuals with the aim of reaching herd immunity. Here we retrospectively explore the effectiveness of this strategy using a stochastic SEIR framework, showing that even under the unrealistic assumption of perfect shielding, hospitals would have been rapidly overwhelmed with many avoidable deaths among lower risk individuals. Crucially, even a small (20%) reduction in the effectiveness of shielding would have likely led to a large increase (>150%) in the number of deaths compared to perfect shielding. Our findings demonstrate that shielding the vulnerable while allowing infections to spread among the wider population would not have been a viable public health strategy for COVID-19 and is unlikely to be effective for future pandemics.

摘要

由冠状病毒SARS-CoV-2引发的新冠疫情,已促使全球各地实施了一系列非药物干预措施以遏制传播。然而,其中一些措施,尤其是封锁措施,所带来的经济和社会成本高昂。针对新冠疫情,另一种广受讨论的公共卫生策略本应是“保护”那些最易感染新冠病毒的人群(尽量减少他们与他人的接触),同时让感染在低风险个体中传播,以期实现群体免疫。在此,我们使用随机易感-暴露-感染-康复(SEIR)模型框架对该策略的有效性进行回顾性探究,结果表明,即便在完美保护这一不切实际的假设条件下,医院仍会迅速不堪重负,低风险个体中会出现许多可避免的死亡病例。至关重要的是,与完美保护相比,即便保护效果仅有小幅(20%)下降,死亡人数可能也会大幅增加(超过150%)。我们的研究结果表明,保护易感染人群同时让感染在更广泛人群中传播,对于新冠疫情而言并非可行的公共卫生策略,而且对未来的疫情可能也不会有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/34a175100148/pgph.0000298.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/c81be368f656/pgph.0000298.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/fbe15c17328d/pgph.0000298.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/ad733c02afb3/pgph.0000298.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/0c16beeee28f/pgph.0000298.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/d39fcc04a478/pgph.0000298.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/34a175100148/pgph.0000298.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/c81be368f656/pgph.0000298.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/fbe15c17328d/pgph.0000298.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/ad733c02afb3/pgph.0000298.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/0c16beeee28f/pgph.0000298.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/d39fcc04a478/pgph.0000298.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10021285/34a175100148/pgph.0000298.g006.jpg

相似文献

1
Critical weaknesses in shielding strategies for COVID-19.新型冠状病毒肺炎防护策略中的关键弱点。
PLOS Glob Public Health. 2022 Apr 26;2(4):e0000298. doi: 10.1371/journal.pgph.0000298. eCollection 2022.
2
Tuberculosis结核病
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.新冠病毒严重感染高风险的5%人群是可识别的,在经济重启时需要予以考虑。
J Psychiatr Pract. 2020 May;26(3):219-227. doi: 10.1097/PRA.0000000000000475.
5
A stochastic agent-based model of the SARS-CoV-2 epidemic in France.基于随机主体的法国 SARS-CoV-2 传染病模型。
Nat Med. 2020 Sep;26(9):1417-1421. doi: 10.1038/s41591-020-1001-6. Epub 2020 Jul 14.
6
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
7
Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.实现美国 COVID-19 疫苗衍生群体免疫阈值
Front Public Health. 2021 Jul 23;9:709369. doi: 10.3389/fpubh.2021.709369. eCollection 2021.
8
Human choice to self-isolate in the face of the COVID-19 pandemic: A game dynamic modelling approach.面对 COVID-19 大流行时人类选择自我隔离:一种博弈动态建模方法。
J Theor Biol. 2021 Jul 21;521:110692. doi: 10.1016/j.jtbi.2021.110692. Epub 2021 Mar 23.
9
Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic?COVID-19 在风湿性疾病患者中的发病率:大流行期间,预先的健康教育是否比防护建议更重要?
Clin Rheumatol. 2021 Apr;40(4):1575-1579. doi: 10.1007/s10067-020-05494-6. Epub 2020 Nov 11.
10
[Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].面对2019冠状病毒病(COVID-19)大流行的卫生专业人员:心理健康风险有哪些?
Encephale. 2020 Jun;46(3S):S73-S80. doi: 10.1016/j.encep.2020.04.008. Epub 2020 Apr 22.

引用本文的文献

1
Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.新冠疫情期间英国实施的非药物干预措施的有效性:一项快速综述。
J Public Health (Oxf). 2025 May 29;47(2):268-302. doi: 10.1093/pubmed/fdaf017.
2
Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.非药物干预措施以降低英国 COVID-19 传播:快速映射综述和交互式证据差距图。
J Public Health (Oxf). 2024 May 29;46(2):e279-e293. doi: 10.1093/pubmed/fdae025.
3
Ethical dilemma arises from optimizing interventions for epidemics in heterogeneous populations.

本文引用的文献

1
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.COVID-19 的错误二分法,以及对公共卫生、COVID-19 症状、SARS-CoV-2 传播、戴口罩和再感染的证据进行的全面回顾。
BMC Infect Dis. 2021 Jul 27;21(1):710. doi: 10.1186/s12879-021-06357-4.
2
Segmentation and shielding of the most vulnerable members of the population as elements of an exit strategy from COVID-19 lockdown.将最脆弱人群进行分类并加以保护,作为从 COVID-19 封锁中退出策略的组成部分。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200275. doi: 10.1098/rstb.2020.0275. Epub 2021 May 31.
3
伦理困境源于如何针对异质人群优化传染病干预措施。
J R Soc Interface. 2024 Feb;21(211):20230612. doi: 10.1098/rsif.2023.0612. Epub 2024 Feb 7.
4
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.英国在 COVID-19 大流行期间对临床脆弱人群实施屏蔽政策的理由:一项定性研究。
BMJ Open. 2023 Aug 4;13(8):e073464. doi: 10.1136/bmjopen-2023-073464.
5
Antigenic evolution of SARS-CoV-2 in immunocompromised hosts.免疫功能低下宿主中新冠病毒的抗原进化
Evol Med Public Health. 2022 Nov 11;11(1):90-100. doi: 10.1093/emph/eoac037. eCollection 2023.
6
Non-pharmaceutical interventions and the emergence of pathogen variants.非药物干预措施与病原体变体的出现。
Evol Med Public Health. 2022 Dec 19;11(1):80-89. doi: 10.1093/emph/eoac043. eCollection 2023.
Herd immunity.
群体免疫。
Curr Biol. 2021 Feb 22;31(4):R174-R177. doi: 10.1016/j.cub.2021.01.006. Epub 2021 Jan 12.
4
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic.英格兰在大流行首次高峰后 SARS-CoV-2 抗体流行率。
Nat Commun. 2021 Feb 10;12(1):905. doi: 10.1038/s41467-021-21237-w.
5
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.非药物干预措施对 130 个国家和地区的 SARS-CoV-2 传播的影响。
BMC Med. 2021 Feb 5;19(1):40. doi: 10.1186/s12916-020-01872-8.
6
Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study.利用多事件研究估计非药物干预对 COVID-19 发病率和人口流动模式的全球影响。
Sci Rep. 2021 Jan 21;11(1):1972. doi: 10.1038/s41598-021-81442-x.
7
COVID-19 and the Swedish enigma.新冠疫情与瑞典之谜。
Lancet. 2021 Jan 23;397(10271):259-261. doi: 10.1016/S0140-6736(20)32750-1. Epub 2020 Dec 23.
8
Coping Using Sex During the Coronavirus Disease 2019 (COVID-19) Outbreak in the United Kingdom.在英国 2019 冠状病毒病(COVID-19)爆发期间,通过性行为应对。
J Sex Med. 2021 Jan;18(1):50-62. doi: 10.1016/j.jsxm.2020.11.002. Epub 2020 Nov 27.
9
Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.意识驱动的行为改变可以改变疫情的形态,使其从峰值向高原、肩部和波动转变。
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32764-32771. doi: 10.1073/pnas.2009911117. Epub 2020 Dec 1.
10
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.在 2020 年春季大流行期间估计 SARS-CoV-2 在纽约市的感染病死率:基于模型的分析。
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.